**Market Conditions**: Overall market sentiment, economic indicators, and global events influence investor confidence and trading activity, impacting stock prices. **Financial Performance**: Gilead's revenue, earnings, and profitability reports significantly affect investor perceptions and valuation. **Pipeline Developments**: Progress in Gilead's drug development pipeline, including clinical trial results and regulatory approvals, directly influences future growth prospects. **Competitor Actions**: Activities of competing pharmaceutical companies, such as new drug launches or patent challenges, can impact Gilead's market share and revenue. **Regulatory Environment**: Changes in healthcare regulations, drug pricing policies, and intellectual property laws can affect Gilead's profitability and market access. **Investor Sentiment**: Investor expectations, news coverage, and analyst ratings drive demand and supply for Gilead's stock. **Product Sales**: Sales performance of Gilead's key products, particularly HIV and hepatitis treatments, are crucial indicators of revenue and market position.